Research

Brain research foundation lauds VU’s Winder, Park

Vanderbilt University’s Danny Winder, Ph.D., professor of Molecular Physiology and Biophysics, is among 15 scientists nationwide to receive NARSAD Distinguished Investigator Grants this fall for their “cutting-edge” research.

Andries Zijlstra, Ph.D., and colleagues are studying a biomarker that can help predict prostate cancer recurrance. (photo by Susan Urmy)

Predictor of prostate cancer outcomes identified

Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread.

Deciphering DNA code

First-ever study uses EMRs to spot new disease associations

Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology.

(iStockphoto)

VU researchers report G protein advancement that could lead to more effective drugs

Thanks in part to a computer program named “Rosetta,” Vanderbilt University researchers are closer to understanding how the ubiquitous G protein is activated – a discovery that could lead to the design of more specific and effective drugs.

Autism narrows brain’s reward response

MRI brain scans reveal that children with autism spectrum disorders respond to a narrower range of familiar rewards.

(iStockphoto.com)

Mitochondrial mutations not random

A study of mitochondrial DNA mutations suggests they result from a process that selects for particular mutations in certain tissues.

1 154 155 156 157 158 210